Benjamin is a business-minded and purpose driven leader in the pharmaceutical industry with a strong scientific background and cross-cultural experience. He is currently Executive Director Translational Medicine and Clinical Pharmacology & Head of US Pharmacometrics at Boehringer Ingelheim. Benjamin is experienced in all phases of drug development including regulatory submissions in the therapeutic areas respiratory, immunology, cardiovascular, metabolism and central nervous system. In 2019, he was recognized with outstanding young alumni award “40 Gators Under 40” by the University of Florida. His key skills comprise understanding complexity and communicating it in a digestible and customized manner, developing and leading individuals and groups, and designing and executing strategies in the pharmaceutical industry. Benjamin holds an adjunct faculty appointment at University of Florida Center of Pharmacometrics and Systems Pharmacology, published multiple articles in peer-reviewed journals and received invitations to present at academic institutions and scientific conferences. Benjamin has a successful track record of applying situational leadership principles with direct reports and in a matrix environment. He is strongly convinced and role model that healthy work-life-balance is key for sustainable career success.